disease, the prognosis is poor with an average overall survival of 24-48 months. 1 Therefore, further investigation is required to discover therapies with new targets involving the AR signaling pathway that can effectively treat or prevent the progression of disease in PC patients.
Tripartite motif family proteins possess three key structures such as the RING finger, B-box, and coiled-coil domains. It is also known that these unique proteins could function as E3 ubiquitin ligases that are crucial in the process of ubiquitination. 6, 7 In addition, these proteins are considered to regulate biological functions such as cell proliferation, [8] [9] [10] [11] DNA repair, [12] [13] [14] signal transduction, 15 and apoptosis. 16 There are many reports suggesting its association with various cancers. [7] [8] [9] [10] [11] 13, 14, 16, 17 Tripartite motif 36 was first reported as a novel haploid germ cell-specific RING finger protein that is involved in the acrosome reaction. 18 Later, Balint et al 19 identified TRIM36 from the tumor suppressor gene region at chromosome 5q22.3. After being identified as an androgen-responsive gene, 20 subsequent reports revealed its association with the microtubule-binding process, 21 which affects the cell cycle. 22 In the present study, we investigated the clinical impact and tumor-suppressive role of TRIM36 on carcinogenesis of PC. 
| MATERIAL S AND ME THODS

| Patient characteristics and tissue preparation
Ninety
| Immunostaining and immunohistochemical assessment
Immunohistochemistry for TRIM36 expression was carried out using the streptavidin-biotin method as previously described. 11 We used 1:200 diluted rabbit polyclonal Ab to TRIM36 for the primary Ab.
Sections were well washed in Tris-buffered saline with Tween-20 after applying primary antibody overnight at 4°C. Sections were incubated with CSII (Dako, Carpinteria, CA, USA). For negative controls, normal rabbit IgG was used. All sections were counterstained using Carracci's hematoxylin.
Immunostained slides were evaluated for IR scores as described previously. 23 Briefly, IR was evaluated by the sum of intensity and area score of immunostaining. Intensity score was rated from 0 to 3+ (0, none; 1, weak; 2, moderate; 3, strong), and area score was rated from 0 to 5 (0, none; 1, <1/100; 2, 1/100-1/10; 3, 1/10-1/3; 4, 1/3-2/3; 5, >2/3 of the total area). The TRIM36 IR was considered "high" when the IR sum score was 4+ or higher. A score of 4+ was considered the cut-off point, as the median value of the sum score was 4+, and the mean score was 3.49. The optimal cut-off value in the receiver operating characteristic curve analysis for predicting cancer-specific survival was IR sum 3+ in PC patients. Two observers (YY and NK) evaluated the slides, and a third observer (TF) estimated the scores of the slides in case of disagreement between the 2 observers.
| Cell culture and reagents
293T cells were grown in DMEM supplemented with 10% FBS, 50 U/mL penicillin, and 50 μg/mL streptomycin. LNCaP, 22Rv1, and DU145 cells were grown in RPMI medium supplemented with 10%
FBS, 50 U/mL penicillin, and 50 μg/mL streptomycin. All prostate cancer cell lines were validated as the expected cell type by short tandem repeat analyses in 2015. The antibodies used in this study were anti-TRIM36 from Thermo Fisher Scientific (cat#PA5-28401;
Tokyo, Japan), anti-AR (H-280) from Santa Cruz Biotechnology (Santa Cruz, CA, USA), β-actin from Sigma (St. Louis, MO, USA),
anti-TNFSF10 (sc-8440; Santa Cruz Biotechnology), and anti-BAX (sc-493; Santa Cruz Biotechnology). The following reagents were purchased from the indicated companies: DHT (Wako, Saitama, Japan), bicalutamide (Sigma Aldrich Japan, Tokyo, Japan), crystal violet (Nacalai Tesque, Tokyo, Japan).
| Plasmid construction and transfection
Human TRIM36 cDNA was amplified by PCR. The generated amplicon was subcloned into pCDNA3 (Invitrogen, St. Louis, MO, USA)
with an N-terminal His tag to generate mammalian expression plasmid. Cells were cultured in 6-well plates 24 hours before transfection. Transfection of expression vector containing TRIM36 cDNA or empty vector (control) was carried out using X-tremeGENE (Sigma Aldrich Japan), according to the manufacturer's protocol. The cell extracts were analyzed after 72 hours by western blotting.
| Western blot analysis
Western blot analysis was undertaken as previously described. 
| RNA extraction and qRT-PCR
Total RNA extraction was carried out using ISOGEN reagent (Nippon Gene, Tokyo, Japan), and first-strand cDNA was generated by using PrimeScript (Takara, Kyoto, Japan). The generated cDNA was subjected to real-time PCR using an Applied Biosystems
Step one plus real-time PCR system based on SYBR Greenfluorescence (NIPPON Genetics, Tokyo, Japan). mRNA expression levels were normalized by GAPDH, and qRT-PCR was undertaken as previously described. 24 The following PCR primer sequences were used for qRT-PCR: GAPDH targeting AR (#1 S1539 and #2 S1538) were purchased from Thermo Fisher Scientific.
| Cell proliferation assay
LNCaP and 22RV1 cells were seeded in 96-well plates 24 hours before transfection. The MTS assay was carried out using the Cell Titer 96 Aqueous One Solution Cell Proliferation Assay (Promega, Osaka, Japan) according to the manufacturer's instructions after transfection. Assays were carried out in 6 wells, and data are presented as mean value ± SD.
| Analysis of cell viability
LNCaP cells were seeded in 24-well plates 24 hours before transfection. Cell viability was measured using crystal violet staining. The numbers of stained cells were counted under a microscope. Assays were carried out in quintuplicate, and data are presented as mean value ± SD.
| Cell migration assay
The migration assay was carried using a cell culture insert attached with 
| Cell apoptosis assay
We carried out the TUNEL assay using the DEADEND Fluorometric TUNEL System (Promega, Madison, WI, USA) to evaluate effect of TRIM36 knockdown for apoptosis in PC cells. Prostate cancer cells Immunoreactivity score was evaluated by using the sum of intensity (0, none; 1, weak; 2, moderate; 3, strong) and area score (0, none; 1, <1/100; 2, 1/100-1/10; 3, 1/10-1/3; 4, 1/3-2/3; 5, >2/3 of the total area).PSA, prostate-specific antigen. High GS (GS ≥ 8) and high pTstage (pT ≥ 3) were significantly associated with low IR of TRIM36 are indicated in bold. Logistic regression models were used for univariate and multivariate analyses. P value of <.05 was considered to be statistically significant. CI, confidence interval; IR score; immunoreactivity score (sum of intensity and area scores); OR, odds ratio; PSA, prostate-specific antigen; TRIM36, tripartite motif 36. Multivariate analysis showed that GS and TRIM36 IR score were significantly associated with cancer-specific survival are indicated in bold.
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elsewhere. After incubating for 24 hours, control cells were treated with DTX (1 nmol/L) and replated to poly-l-lysine coated glass (Matsunami Glass Industries, Osaka, Japan) inside a 24-well culture plate. Seventy-two hours after transfection, cells were treated with TUNEL staining according to the manufacturer's protocol. Nuclear staining was carried out using DAPI. Signals were captured using a digital microscope (Fluoview FV10i; Olympus, Tokyo, Japan).
Percentages of apoptotic cells were evaluated in 3 randomly selected fields (×100), and data are presented as mean value ± SD.
| Microarray analysis
In order to evaluate the target pathway and regulated genes 
| Statistical analyses
We used the statistical software JMP Pro version 11.0. 
| RE SULTS
| Tripartite motif 36 IR is significantly associated with Gleason score, pT stage, progression-free survival, and cancer-specific survival
Representative immunostaining pictures of TRIM36 and controls are shown in Figure 1A -F. Tripartite motif 36 immunostaining was observed both in the nuclei and cytoplasm. The rate of high TRIM36 IR (sum ≥4) was significantly higher in patients with lower Gleason score and pT stage (P = .0003 and P = .028, respectively, as shown in Table 1 ). KaplanMeier curves were analyzed for difference between patients with low and high TRIM36 IR. Patients with low TRIM36 IR had significantly poor progression-free survival and cancer-specific survival compared to those with high TRIM36 IR (P = .045 and P = .0035, respectively, as shown in Figure 1G ,H). Moreover, multivariate analysis using a logistic regression model revealed that TRIM36 IR was an independent predictor of cancer-specific survival in patients with PC (P = .014; Table 2 ). 
| Tripartite motif 36 is induced by androgen stimulation in LNCaP and 22Rv1 cells
| Overexpression of TRIM36 promoted proliferation and migration of PC cells
LNCaP, 22Rv1, and DU145 cells were transiently transfected with TRIM36 ( Figures 3A,B, S2A 
| Tripartite motif 36 regulates the apoptosisrelated pathway and promotes apoptosis in PC cells
Furthermore, we investigated target genes and pathways that are potentially regulated by TRIM36 overexpression and knockdown in LNCaP cells using microarray analysis. With microarray data for TRIM36 overexpression, we identified 197 genes that were upregulated by TRIM36 (fold change 1.7-6.1) as well as 185 genes downregulated (fold change 0.1-0.5). Interestingly, pathway analysis of these TRIM36-regulated genes indicated that the apoptosis-related pathway was significantly upregulated by TRIM36 ( Figure 4A ). The T-cell receptor signaling pathway was significantly downregulated by TRIM36 ( Figure 4B ).
As shown in Figure 4C , we identified BAX and TNFSF10 as rep- BAX and TNFSF10 ( Figures 5A-C, S4A,B and S5A,B) . Furthermore, TRIM36 knockdown decreased mRNA levels of BAX and TNFSF10
( Figures 5D,E and S4C ). We also undertook TUNEL assays to evaluate apoptosis in TRIM36-overexpressing LNCaP, 22Rv1, and DU145 
| D ISCUSS I ON
We previously identified TRIM36 as an androgen-dependent gene by combining the results of 5′-cap analysis of gene expression and ChIP analysis in PC cells. 20 Further investigation revealed that TRIM36 expression, along with the other 9 signals, correlated with cancer-specific survival in PC. 25 The present study shows that the androgen-responsive TRIM36 has a significant clinical impact on progression-free survival and cancer-specific survival. At a molecular level, TRIM36 overexpression significantly suppressed cell growth and migration, and promoted apoptosis in PC cells. Furthermore, TRIM36 knockdown accelerated cell growth and migration, and suppressed apoptosis. Moreover, we investigated the target pathways of TRIM36 by microarray and found that the apoptosis-related pathway was significantly regulated by TRIM36. Therefore, TRIM36 might be involved in a tumor-suppressive role by promoting apoptosis in PC, as summarized in Figure 6G . This finding would be unique, as it is well known that androgen stimulates PC growth, and yet, TRIM36
is also induced by androgen to promote apoptosis. This paradoxical finding might be explained by previously reported in vitro and in vivo studies that showed androgens might repress some types of CRPC cells. Androgen-repressed human PC cells were repressed by DHT in vitro in a concentration-dependent manner. 26 In addition, a phase II multicohort study by Teply et al 27 has shown that bipolar androgen therapy is clinically effective for CRPC. Therefore, it is tempting to speculate that the tumor-suppressive function of TRIM36 might be involved in the molecular mechanisms of bipolar androgen therapy.
Tripartite motif 36 has two potential molecular functions that are based on two distinct structures. The first structure is the key domains of the TRIM family, containing RING finger, two B-boxes, and coiled-coil domains. Possessing the RING finger domain enables the TRIM proteins to function as E3 ubiquitin ligases that are required in the ubiquitination process. 6, 28 Tripartite motif 36 has been shown to exhibit ubiquitination activity in the presence of E1, E2, ubiquitin, and ATP, which strongly suggest that TRIM36 is a bona fide E3
ligase. 22 As the second structure, TRIM36 possesses COS and fibronectin type III repeat, the most salient characteristic features of subfamily C-I proteins. 29 Notably, other TRIM proteins included in this subgroup are TRIM1, TRIM9, TRIM18, TRIM46, and TRIM67. The COS is considered to be the key domain in microtubule-binding. 21 For instance, the COS domain together with the coiled-coil domain of TRIM18 can directly bind to microtubules. 30 One of the other subfamily C-I proteins, TRIM46, controls neuronal polarity and axon specification to define the axonal cytoskeletal compartment for regulating microtubule organization. 31 Using a bioinformatics approach, Short et al proposed an association between the subfamily C-I proteins and microtubule binding. 22 As for TRIM36, Miyajima et al found that it interacts with the kinetochore protein CENP-H, and delays cell cycle progression, which may lead to the suppression of cell growth. 21 Therefore, it would be postulated that TRIM36 might possess the function of both E3 ubiquitin ligase and microtubule binding.
Our results revealed an association between TRIM36 and the apoptosis-related pathway. Recently, a different group has reported that TRIM36 enhanced antiandrogen efficacy by inhibiting MAPK/ ERK signaling pathways in PC. 32 Tripartite motif 36 might have an association with the microtubule-binding mechanism that leads to decelerating the cell cycle and regulating apoptosis. According to our microarray results, the apoptosis-related pathway was one of the top TRIM36-regulated pathways. Genes included in this pathway were BAX and TNFSF10, which are key players of the apoptosis mechanism. BAX is encoded by six exons and has extensive amino acid homology with Bcl-2. 33 BAX promotes apoptosis by heterodimerizing with Bcl-2, a known inhibitor of apoptotis. 34 In PC, several signals induce BAX to enhance apoptosis. [35] [36] [37] [38] In the present study, TNFSF10
was also significantly regulated by TRIM36. Additionally, TNFSF10 is known to induce autophagy by regulating TNF receptor-associated factor 2-and receptor-interacting serine/threonine-protein kinase 1-mediated MAPK8/JNK activation. 39 Taxanes, especially DTX, have high affinity for microtubules and inhibit microtubular depolymerization to promote apoptotic cell death of PC. 40, 41 It is well known that this chemotherapeutic F I G U R E 6 Knockdown of tripartite motif 36 (TRIM36) inhibits mRNAs of BAX and TNFSF10 and also attenuates apoptosis in docetaxel (DTX)-treated LNCaP cells. A, B, mRNA levels of BAX (A) and TNFSF10 (B) were determined in siTRIM36-transfected LNCaP cells after DTX (1 nmol/L) treatment by quantitative RT-PCR (n = 3, bar = SD; *P < .05, **P < .001, ***P < .0001, Student's t test with the potential function that can be speculated from the molecular features of TRIM36.
In conclusion, TRIM36 has a significant clinical impact on prognosis and plays a tumor-suppressive role in PC by promoting the apoptosis-related pathway. Proteomics investigation will be required in future studies in order to elucidate the tumor-suppressive mechanism of TRIM36 in PC.
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